Crossmark

Lack of evolutionary convergence in multiple primary lung cancer suggests insufficient specificity of personalized therapy

Crossref DOI link: https://doi.org/10.1016/j.jgg.2022.11.005

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cheng, Hua

Guo, Ziyan https://orcid.org/0000-0001-7745-3073
Zhang, Xiaoyu

Wang, Xiao-Jin

Li, Zizhang

Huo, Wen-Wen

Zhong, Hong-Cheng

Li, Xiao-Jian

Wu, Xiang-Wen

Li, Wen-Hao

Chen, Zhuo-Wen

Wu, Tian-Chi

Gan, Xiang-Feng

Zhong, Bei-Long

Lyubetsky, Vassily A.

Rusin, Leonid Yu

Yang, Junnan

Zhao, Qiyi

Cao, Qing-Dong

Yang, Jian-Rong https://orcid.org/0000-0002-7807-9455
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31871320, 81830103)

Key Technologies Research and Development Program (2021YFA1302500, 2021YFF1200904)

National Key Research and Development Program of China

Science and Technology Planning Project of Guangdong Province (2014A030304053)
License Information

Text and Data Mining valid from 2023-05-01

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2022-12-08
More Information

This article is maintained by: Elsevier

Article Title: Lack of evolutionary convergence in multiple primary lung cancer suggests insufficient specificity of personalized therapy

Journal Title: Journal of Genetics and Genomics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jgg.2022.11.005

Content Type: article

Copyright: © 2022 The Authors. Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press.